| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 3 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 3 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 3 |
| 3 | PREDNISOLONE | 2 |
| 4 | PREDNISOLONE ORAL | 2 |
| 5 | PREDNISOLONE ORAL SOLUTION | 2 |
| 6 | RITUXIMAB | 2 |
| 7 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | 1 |
| 8 | ADALIMUMAB | 1 |
| 9 | ADALIMUMAB-AATY | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBRITUMOMAB TIUXETAN | 1 | 0.0007 |
| 1 | CHLORAMBUCIL | 1 | 0.0003 |
| 2 | MESALAMINE | 1 | 0.0000 |
| 3 | VINCRISTINE SULFATE | 1 | 0.0000 |
| 4 | IRBESARTAN | 1 | 0.0000 |
| 5 | ADALIMUMAB-FKJP | 1 | 0.0000 |
| 6 | ADALIMUMAB-AATY | 1 | 0.0000 |
| 7 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | 1 | 0.0000 |
| 8 | ADALIMUMAB-ADAZ | 1 | 0.0000 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 3 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 4 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 2 |
| 2 | Corticosteroid [EPC] | 2 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 2 |
| 4 | Aminosalicylate [EPC] | 1 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 1 |
| 6 | Platinum-based Drug [EPC] | 1 |
| 7 | Topoisomerase Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Alkylating Drug [EPC] | 4 | 0.0000 |
| 1 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Aminosalicylate [EPC] | 1 | 0.0000 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 2 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 1 | 0.0000 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 2 | 0.0000 |
| 7 | Corticosteroid [EPC] | 2 | 0.0000 |